14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

$0.0649 (-13.35%)

Volume: 472.892k

Closed: May 19, 2022

Hollow Logo Score: -5.478

Advaxis Stock Forecast

BUY SELL NASDAQ:ADXS
$0.0649 (-13.35%)

Volume: 472.892k

Closed: May 19, 2022

Score Hollow Logo -5.478

ADXS Stock Trend

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.0607 is broken, it will firstly indicate a stronger fall rate.

Given the current short-term trend, the stock is expected to fall -35.22% during the next 3 months and, with a 90% probability hold a price between $0.0393 and $0.0599 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2022-05-23 $0.0599 $0.0758 $0.0917
2022-05-24 $0.0591 $0.0750 $0.0909
2022-05-25 $0.0582 $0.0741 $0.0900
2022-05-26 $0.0574 $0.0733 $0.0892
2022-05-27 $0.0566 $0.0725 $0.0884
2022-05-31 $0.0558 $0.0717 $0.0876
2022-06-01 $0.0549 $0.0708 $0.0867
2022-06-02 $0.0541 $0.0700 $0.0859
2022-06-03 $0.0533 $0.0692 $0.0851
2022-06-06 $0.0525 $0.0684 $0.0843
2022-06-07 $0.0516 $0.0675 $0.0834
2022-06-08 $0.0508 $0.0667 $0.0826
2022-06-09 $0.0500 $0.0659 $0.0818
2022-06-10 $0.0492 $0.0651 $0.0810
2022-06-13 $0.0483 $0.0642 $0.0801
2022-06-14 $0.0475 $0.0634 $0.0793
2022-06-15 $0.0467 $0.0626 $0.0785
2022-06-16 $0.0459 $0.0618 $0.0777
2022-06-17 $0.0450 $0.0609 $0.0768
2022-06-21 $0.0442 $0.0601 $0.0760
2022-06-22 $0.0434 $0.0593 $0.0752
2022-06-23 $0.0426 $0.0585 $0.0744
2022-06-24 $0.0417 $0.0576 $0.0735
2022-06-27 $0.0409 $0.0568 $0.0727
2022-06-28 $0.0401 $0.0560 $0.0719
2022-06-29 $0.0393 $0.0552 $0.0711
2022-06-30 $0.0384 $0.0543 $0.0702
2022-07-01 $0.0376 $0.0535 $0.0694
2022-07-05 $0.0368 $0.0527 $0.0686
2022-07-06 $0.0360 $0.0519 $0.0678

About Advaxis

Advaxis Advaxis, Inc., a clinical stage biotechnology company, focuses on the discovery, development, and commercialization of Lm-LLO cancer immunotherapies in the United States. Its lead product Axalimogene filolisbac (ADXS-HPV), an Lm-LLO immunotherapy product candidate, which completed its Phase II study used for the treatment of human papilloma virus (HPV) associated cancers, including cervical, head and neck, and anal cancer. The company is also dev... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT